Acelrx Pharmaceuticals reported $-8674000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.67M 0.76M
Baxter International BAX:US $ 252M 181M
Becton, Dickinson and BDX:US $ 360M 94M
Cara Therapeutics CARA:US $ -4206000 23.54M
Intra Cellular Therapies ITCI:US $ -86.6M 14.48M
Johnson & Johnson JNJ:US $ 4814M 335M
Pain Therapeutics PTIE:US $ -19.33M 1.8M
Pfizer PFE:US $ 9905M 2042M
Smiths SMIN:LN 1.12B 966M
Teva Pharmaceutical TEVA:IT -233000000 722M
Xeris Pharmaceuticals Inc XERS:US -33714000 17.08M